As far as cancer pathobiology is concerned, the role of PARPs is mainly triggered by supervening DNA damage and repair mechanisms; in cells bearing homologous recombination (HR) defects, as in the case of BRCA1/2 mutations, the role of PARP becomes even more important in supporting alternative DNA repair pathways. Here, PARP1 is linked to cancer.